IDEXX LABORATORIES INC /DE Other Comprehensive Income (Loss), Net of Tax
IDEXX LABORATORIES INC /DE (IDXX) reported Other Comprehensive Income (Loss), Net of Tax of $1.40 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-04
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was $1.40M, a 89.33% decline year-over-year.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was $3.90M, a 9.85% increase year-over-year.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), net of tax for the quarter ending 2025-06-30 was $13.14M.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), net of tax for the quarter ending 2025-03-31 was $3.55M.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), net of tax for fiscal 2025 was $24.80M.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), net of tax for fiscal 2024 was -$22.44M, a 440.50% decline from fiscal 2023.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), net of tax for fiscal 2023 was $6.59M.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), net of tax for fiscal 2022 was -$24.31M, a 18658.78% decline from fiscal 2021.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.40M 10-Q · filed 2026-08-04 | $5.31M 10-Q · filed 2026-08-04 | ||
| 2026-03-31 | $3.90M 10-Q · filed 2026-05-05 | |||
| 2025-12-31 | $24.80M 10-K · filed 2026-02-20 | |||
| 2025-06-30 | $13.14M 10-Q · filed 2026-08-04 | $16.70M 10-Q · filed 2026-08-04 | ||
| 2025-03-31 | $3.55M 10-Q · filed 2026-05-05 | |||
| 2024-12-31 | -$22.44M 10-K · filed 2026-02-20 | |||
| 2024-03-31 | -$9.19M 10-Q · filed 2025-05-01 | |||
| 2023-12-31 | $6.59M 10-K · filed 2026-02-20 | |||
| 2023-06-30 | $2.95M 10-Q · filed 2023-08-01 | $4.13M 10-Q · filed 2023-08-01 | $7.23M derived: sum of 3 quarters · filed 2025-02-21 | -$5.96M derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-03-31 | $1.18M 10-Q · filed 2023-08-01 | $4.28M derived: sum of 2 quarters · filed 2025-02-21 | -$8.91M derived: sum of 3 quarters · filed 2025-02-21 | -$29.27M derived: sum of 4 quarters · filed 2025-02-21 |
| 2022-12-31 | $3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | -$10.09M derived: sum of 2 quarters · filed 2025-02-21 | -$30.45M derived: sum of 3 quarters · filed 2025-02-21 | -$24.31M 10-K · filed 2025-02-21 |
| 2022-09-30 | -$13.19M 10-Q · filed 2022-11-01 | -$33.55M derived: sum of 2 quarters · filed 2023-08-01 | -$27.41M 10-Q · filed 2022-11-01 | -$28.84M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | -$20.36M 10-Q · filed 2023-08-01 | -$14.22M 10-Q · filed 2023-08-01 | -$15.65M derived: sum of 3 quarters · filed 2024-02-22 | -$19.31M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $6.14M 10-Q · filed 2023-08-01 | $4.71M derived: sum of 2 quarters · filed 2024-02-22 | $1.04M derived: sum of 3 quarters · filed 2024-02-22 | $12.19M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | -$1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$5.09M derived: sum of 2 quarters · filed 2024-02-22 | $6.05M derived: sum of 3 quarters · filed 2024-02-22 | $131.00K 10-K · filed 2024-02-22 |
| 2021-09-30 | -$3.67M 10-Q · filed 2022-11-01 | $7.48M derived: sum of 2 quarters · filed 2022-11-01 | $1.56M 10-Q · filed 2022-11-01 | $9.87M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $11.14M 10-Q · filed 2022-11-01 | $5.22M 10-Q · filed 2022-08-02 | $13.53M derived: sum of 3 quarters · filed 2023-02-16 | $8.64M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | -$5.92M 10-Q · filed 2022-11-01 | $2.39M derived: sum of 2 quarters · filed 2023-02-16 | -$2.50M derived: sum of 3 quarters · filed 2023-02-16 | -$4.29M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $8.31M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $3.42M derived: sum of 2 quarters · filed 2023-02-16 | $1.63M derived: sum of 3 quarters · filed 2023-02-16 | -$7.43M 10-K · filed 2023-02-16 |
| 2020-09-30 | -$4.89M 10-Q · filed 2021-11-02 | -$6.68M derived: sum of 2 quarters · filed 2021-11-02 | -$15.74M 10-Q · filed 2021-11-02 | -$16.36M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | -$1.79M 10-Q · filed 2021-11-02 | -$10.85M 10-Q · filed 2021-07-30 | -$11.47M derived: sum of 3 quarters · filed 2022-02-16 | -$16.45M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | -$9.06M 10-Q · filed 2021-11-02 | -$9.68M derived: sum of 2 quarters · filed 2022-02-16 | -$14.66M derived: sum of 3 quarters · filed 2022-02-16 | -$15.23M derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | -$617.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | -$5.60M derived: sum of 2 quarters · filed 2022-02-16 | -$6.17M derived: sum of 3 quarters · filed 2022-02-16 | -$4.39M 10-K · filed 2022-02-16 |
| 2019-09-30 | -$4.98M 10-Q · filed 2020-10-29 | -$5.55M derived: sum of 2 quarters · filed 2020-10-29 | -$3.77M 10-Q · filed 2020-10-29 | -$3.38M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-06-30 | -$568.00K 10-Q · filed 2020-10-29 | $1.21M 10-Q · filed 2020-07-31 | $1.60M derived: sum of 3 quarters · filed 2021-02-12 | $1.98M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-03-31 | $1.78M 10-Q · filed 2020-10-29 | $2.17M derived: sum of 2 quarters · filed 2021-02-12 | $2.54M derived: sum of 3 quarters · filed 2021-02-12 | -$5.81M derived: sum of 4 quarters · filed 2021-02-12 |
| 2018-12-31 | $396.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $768.00K derived: sum of 2 quarters · filed 2021-02-12 | -$7.58M derived: sum of 3 quarters · filed 2021-02-12 | -$5.32M 10-K · filed 2021-02-12 |
| 2018-09-30 | $372.00K 10-Q · filed 2019-10-31 | -$7.98M derived: sum of 2 quarters · filed 2019-10-31 | -$5.72M 10-Q · filed 2019-10-31 | -$7.54M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-06-30 | -$8.35M 10-Q · filed 2019-10-31 | -$6.09M 10-Q · filed 2019-08-01 | -$7.91M derived: sum of 3 quarters · filed 2020-02-14 | -$4.17M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-03-31 | $2.26M 10-Q · filed 2019-10-31 | $442.00K derived: sum of 2 quarters · filed 2020-02-14 | $4.18M derived: sum of 3 quarters · filed 2020-02-14 | $4.17M derived: sum of 4 quarters · filed 2020-02-14 |
| 2017-12-31 | -$1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $1.92M derived: sum of 2 quarters · filed 2020-02-14 | $1.91M derived: sum of 3 quarters · filed 2020-02-14 | $6.58M 10-K · filed 2020-02-14 |
| 2017-09-30 | $3.74M 10-Q · filed 2018-11-01 | $3.73M derived: sum of 2 quarters · filed 2018-11-01 | $8.40M 10-Q · filed 2018-11-01 | $433.00K derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-06-30 | -$9.00K 10-Q · filed 2018-08-01 | $4.67M 10-Q · filed 2018-08-01 | -$3.31M derived: sum of 3 quarters · filed 2019-02-15 | -$2.92M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-03-31 | $4.67M 10-Q · filed 2018-05-04 | -$3.30M derived: sum of 2 quarters · filed 2019-02-15 | -$2.91M derived: sum of 3 quarters · filed 2019-02-15 | -$864.00K derived: sum of 4 quarters · filed 2019-02-15 |
| 2016-12-31 | -$7.97M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | -$7.59M derived: sum of 2 quarters · filed 2019-02-15 | -$5.54M derived: sum of 3 quarters · filed 2019-02-15 | -$788.00K 10-K · filed 2019-02-15 |
| 2016-09-30 | $384.00K 10-Q · filed 2017-10-31 | $2.43M derived: sum of 2 quarters · filed 2017-10-31 | $7.18M 10-Q · filed 2017-10-31 | $2.41M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | $2.05M 10-Q · filed 2017-08-01 | $6.80M 10-Q · filed 2017-08-01 | $2.03M derived: sum of 3 quarters · filed 2018-02-16 | -$13.19M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | $4.75M 10-Q · filed 2017-04-28 | -$22.00K derived: sum of 2 quarters · filed 2018-02-16 | -$15.24M derived: sum of 3 quarters · filed 2018-02-16 | -$13.46M derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | -$4.77M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | -$19.99M derived: sum of 2 quarters · filed 2018-02-16 | -$18.21M derived: sum of 3 quarters · filed 2018-02-16 | -$34.19M 10-K · filed 2018-02-16 |
| 2015-09-30 | -$15.22M 10-Q · filed 2016-11-01 | -$13.44M derived: sum of 2 quarters · filed 2016-11-01 | -$29.42M 10-Q · filed 2016-11-01 | -$39.48M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | $1.77M 10-Q · filed 2016-08-02 | -$14.20M 10-Q · filed 2016-08-02 | -$24.27M derived: sum of 3 quarters · filed 2017-02-17 | -$37.31M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | -$15.98M 10-Q · filed 2016-04-29 | -$26.04M derived: sum of 2 quarters · filed 2017-02-17 | -$39.08M derived: sum of 3 quarters · filed 2017-02-17 | -$38.49M derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | -$10.06M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | -$23.10M derived: sum of 2 quarters · filed 2017-02-17 | -$22.52M derived: sum of 3 quarters · filed 2017-02-17 | -$21.69M 10-K · filed 2017-02-17 |
| 2014-09-30 | -$13.04M 10-Q · filed 2015-10-28 | -$12.46M derived: sum of 2 quarters · filed 2015-10-28 | -$11.63M 10-Q · filed 2015-10-28 | -$13.57M derived: sum of 4 quarters · filed 2016-02-17 |
| 2014-06-30 | $586.00K 10-Q · filed 2015-07-30 | $1.41M 10-Q · filed 2015-07-30 | -$531.00K derived: sum of 3 quarters · filed 2016-02-17 | $4.54M derived: sum of 4 quarters · filed 2016-02-17 |
| 2014-03-31 | $823.00K 10-Q · filed 2015-04-28 | -$1.12M derived: sum of 2 quarters · filed 2016-02-17 | $3.95M derived: sum of 3 quarters · filed 2016-02-17 | $2.76M derived: sum of 4 quarters · filed 2016-02-17 |
| 2013-12-31 | -$1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-17 | $3.13M derived: sum of 2 quarters · filed 2016-02-17 | $1.94M derived: sum of 3 quarters · filed 2016-02-17 | -$2.33M 10-K · filed 2016-02-17 |
| 2013-09-30 | $5.07M 10-Q · filed 2014-10-24 | $3.88M derived: sum of 2 quarters · filed 2014-10-24 | -$392.00K 10-Q · filed 2014-10-24 | $983.00K derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-30 | -$1.19M 10-Q · filed 2014-07-25 | -$5.46M 10-Q · filed 2014-07-25 | -$4.09M derived: sum of 3 quarters · filed 2015-02-17 | $1.64M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-31 | -$4.27M 10-Q · filed 2014-04-25 | -$2.89M derived: sum of 2 quarters · filed 2015-02-17 | $2.83M derived: sum of 3 quarters · filed 2015-02-17 | -$7.79M derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $7.10M derived: sum of 2 quarters · filed 2015-02-17 | -$3.53M derived: sum of 3 quarters · filed 2015-02-17 | $511.00K 10-K · filed 2015-02-17 |
| 2012-09-30 | $5.72M 10-Q · filed 2013-10-22 | -$4.90M derived: sum of 2 quarters · filed 2013-10-22 | -$864.00K 10-Q · filed 2013-10-22 | -$4.13M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-06-30 | -$10.62M 10-Q · filed 2013-07-23 | -$6.58M 10-Q · filed 2013-07-23 | -$9.85M derived: sum of 3 quarters · filed 2014-02-18 | -$17.61M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-03-31 | $4.04M 10-Q · filed 2013-04-23 | $772.00K derived: sum of 2 quarters · filed 2014-02-18 | -$6.99M derived: sum of 3 quarters · filed 2014-02-18 | -$106.00K derived: sum of 4 quarters · filed 2014-02-18 |
| 2011-12-31 | -$3.27M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18 | -$11.03M derived: sum of 2 quarters · filed 2014-02-18 | -$4.14M derived: sum of 3 quarters · filed 2014-02-18 | $1.98M 10-K · filed 2014-02-18 |
| 2011-09-30 | -$7.76M 10-Q · filed 2012-10-19 | -$878.00K derived: sum of 2 quarters · filed 2012-10-19 | $5.24M 10-Q · filed 2012-10-19 | |
| 2011-06-30 | $6.88M 10-Q · filed 2012-07-20 | $13.00M 10-Q · filed 2012-07-20 | ||
| 2010-12-31 | $3.13M 10-K · filed 2013-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |